Citius Oncology Inc. (CTOR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.16
-0.05 (-4.13%)
At close: Jan 29, 2025, 3:59 PM
1.12
-3.80%
After-hours Jan 29, 2025, 04:32 PM EST
undefined% (undefined)
Bid | 1.16 |
Market Cap | 82.71M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.31 |
PE Ratio (ttm) | -3.74 |
Forward PE | n/a |
Analyst | Buy |
Ask | 1.25 |
Volume | 52,106 |
Avg. Volume (20D) | 1,985,206 |
Open | 1.24 |
Previous Close | 1.21 |
Day's Range | 1.16 - 1.24 |
52-Week Range | 0.85 - 49.00 |
Beta | undefined |
About CTOR
A detailed description of the company is not yet available....
Analyst Forecast
According to 2 analyst ratings, the average rating for CTOR stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 287.93% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%